Ellis Investment Partners, LLC Astrazeneca PLC Transaction History

Ellis Investment Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $583 - $1,493	11 Added 0.74%	1,507 $82,000
Q2 2022 Aug 01, 2022	SELL	$59.26 - $71.14 $2,548 - $3,059	-43 Reduced 2.79%	1,496 $98,000
Q1 2022 May 03, 2022	SELL	$55.72 - $67.12 $2,953 - $3,557	-53 Reduced 3.33%	1,539 $102,000
Q4 2021 Feb 01, 2022	BUY	$54.02 - $63.83 $49,482 - $58,468	916 Added 135.5%	1,592 $92,000
Q3 2021 Oct 21, 2021	BUY	$55.56 - $60.79 $222 - $243	4 Added 0.6%	676 $40,000
Q2 2021 Jul 26, 2021	SELL	$48.42 - $60.18 $48 - $60	-1 Reduced 0.15%	672 $40,000
Q1 2021 May 03, 2021	SELL	$47.16 - $54.44 $14,053 - $16,223	-298 Reduced 30.69%	673 $33,000
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $371 - $427	7 Added 0.73%	971 $53,000
Q2 2020 Jul 13, 2020	BUY	$43.1 - $55.31 $16,378 - $21,017	380 Added 65.07%	964 $51,000
Q1 2020 Apr 17, 2020	BUY	$37.79 - $51.33 $3,514 - $4,773	93 Added 18.94%	584 $25,000
Q3 2019 Oct 09, 2019	BUY	$40.12 - $45.47 $200 - $227	5 Added 1.03%	491 $21,000
Q2 2019 Jul 24, 2019	SELL	$37.28 - $41.68 $714,433 - $798,755	-19,164 Reduced 97.53%	486 $20,000
Q1 2019 Apr 24, 2019	BUY	$35.49 - $43.02 $697,378 - $845,343	19,650 New	19,650 $19,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.